AnticoagEvaluator v5.0

American College of Cardiology Foundation

About this app

Developer Description

Make informed anti thrombotic therapy decisions for AF patients.

Make well-informed decisions on anti thrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for anti thrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com

What's New

This app has been updated with an enhanced Risk Bar which showcases CHA2DS2-VASc and ATRIA stroke risk point scores for all patients alongside the stroke risk magnitude percentage. In addition, a visual display bug was fixed and standard notification functionality was incorporated.

Version Information

Version: 5.0
Downloads: 10K+
Updated on: Nov 21, 2024
Released: Dec 9, 2015
Requires: Android 7.0

Statistics

Google Play Rating History

Current

Average

Range

Rating Distribution

Total Ratings:

Downloads Over Time

AnticoagEvaluator has been downloaded times.

Total Downloads

Last 30 Days

Avg Daily Est.

Shaded area shows 30-day prediction based on historical trends

Historical data collection started recently. More data points will be available over time.

AnticoagEvaluator users say on Google Play

★★★★★

A Google user

Very useful app

★

anisah ahmad

Used to be so easy to work out crcl and then it would give you the dose I used to recommend it to all newly qualified medical staff Now it mandates that you fill in all of the patient details making it much harder and less efficient